title: [Sepsis. Update 2012].
authors.affiliation: Klinik I für Innere Medizin der Universität zu Köln, Kerpener Strasse 62, Köln. matthias.kochanek@uk-koeln.de
authors.forename: M
authors.initials: M
authors.lastname: Kochanek
authors.forename: A
authors.initials: A
authors.lastname: Shimabukuro-Vornhagen
authors.forename: M
authors.initials: M
authors.lastname: von Bergwelt-Baildon
authors.forename: G
authors.initials: G
authors.lastname: Michels
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001372:Aza Compounds / Q000627:therapeutic use; D001810:Blood Volume / Q000502:physiology; D002496:Central Venous Pressure / Q000502:physiology; D004359:Drug Therapy, Combination; D019348:Empiricism; D005440:Fluid Therapy / Q000379:methods; D024841:Fluoroquinolones; D019983:Guideline Adherence; D006801:Humans; D000077266:Moxifloxacin; D009102:Multiple Organ Failure / Q000188:drug therapy / Q000401:mortality / Q000503:physiopathology; D011486:Protein C / Q000627:therapeutic use; D011804:Quinolines / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000627:therapeutic use; D018805:Sepsis / Q000401:mortality / Q000503:physiopathology / Q000628:therapy*; D016019:Survival Analysis; D018746:Systemic Inflammatory Response Syndrome / Q000401:mortality / Q000503:physiopathology / Q000628:therapy*
chemical_list: D000900:Anti-Bacterial Agents; D001372:Aza Compounds; D024841:Fluoroquinolones; D011486:Protein C; D011804:Quinolines; D011994:Recombinant Proteins; C421124:drotrecogin alfa activated; D000077266:Moxifloxacin